Showing results (1011-1020 of 5,692) with videos related to

Sort By:
Pageof 570
The Oncologist|July 25, 2019
18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CTCheng Liu, Chengcheng Gong, Shuai Liu, et al.
The Oncologist|August 2, 2019
Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic PathologySharyl J Nass, Michael B Cohen, Ritu Nayar, et al.
The Oncologist|February 5, 2008
Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tractReshma L Mahtani, John S Macdonald
The Oncologist|April 2, 2008
Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanismsLinda Vahdat
The Oncologist|April 2, 2008
Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind studyFlorian Strasser, Ruth Demmer, Christel Böhme, et al.
The Oncologist|July 1, 2008
Venous thromboembolic events and erythropoiesis-stimulating agents: an updateMario Dicato
The Oncologist|April 9, 2014
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancerJoshua A Roth, Paul Billings, Scott D Ramsey, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
The Oncologist|April 1, 2014
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: north japan lung cancer group trial 0801Makoto Maemondo, Akira Inoue, Shunichi Sugawara, et al.
The Oncologist|February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal TreatmentPierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Pageof 570